SECOND GENERATION DRUG-ELUTING STENT IMPLANTATION FOLLOWED BY SIX- VERSUS TWELVE-MONTH DUAL ANTIPLATELET THERAPY
Colombo A., Chieffo A., Frasheri A., et al. Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy: The SECURITY Randomized Clinical Trial // J. Am. Coll. Cardiol.– 2014. – Vol. 64. – P. 2086–2097.
Saved in:
| Format: | Article |
|---|---|
| Language: | Russian |
| Published: |
Sklifosovsky Research Institute for Emergency Medicine, Public Healthcare Institution of Moscow Healthcare Department
2016-03-01
|
| Series: | Неотложная медицинская помощь |
| Online Access: | https://www.jnmp.ru/jour/article/view/216 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Very Late Stent Thrombosis 42 Months after Implantation of Sirolimus-Eluting Stent and Discontinuation of Antiplatelet Therapy
by: Dirk Sibbing, et al.
Published: (2009-01-01) -
Comparison of 6-Month and Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Biodegradable Polymer Everolimus-Eluting Stent
by: Yong-Hoon Yoon, et al.
Published: (2022-01-01) -
Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
by: Wen-Juan Xiu, et al.
Published: (2018-01-01) -
Predictors and Long‐Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug‐Eluting Stents (ADAPT‐DES) Intravascular Ultrasound Substudy
by: Bin Wang, et al.
Published: (2016-12-01) -
Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
by: Yi-Xing Yang, et al.
Published: (2020-01-01)